MwanzoGRF • BME
Grifols SA Class A
€ 8.51
25 Apr, 22:03:00 GMT +2 · EUR · BME · Kanusho
HisaHisa zinazouzwa ES
Bei iliyotangulia
€ 8.45
Bei za siku
€ 8.45 - € 8.57
Bei za mwaka
€ 7.32 - € 11.35
Thamani ya kampuni katika soko
5.24B EUR
Wastani wa hisa zilizouzwa
1.39M
Uwiano wa bei na mapato
36.88
Mgao wa faida
-
Ubadilishanaji wa msingi
BME
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(EUR)Des 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
1.98B11.66%
Matumizi ya uendeshaji wa biashara
353.12M20.32%
Mapato halisi
68.97M76.86%
Kiwango cha faida halisi
3.4958.64%
Mapato kwa kila hisa
EBITDA
495.68M-11.49%
Asilimia ya kodi ya mapato
60.20%
Jumla ya mali
Jumla ya dhima
(EUR)Des 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
1.00B55.40%
Jumla ya mali
21.41B1.97%
Jumla ya dhima
12.80B-5.05%
Jumla ya hisa
8.61B
hisa zilizosalia
680.41M
Uwiano wa bei na thamani
0.98
Faida inayotokana na mali
5.08%
Faida inayotokana mtaji
5.79%
Mabadiliko halisi ya pesa taslimu
(EUR)Des 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
68.97M76.86%
Pesa kutokana na shughuli
514.62M208.54%
Pesa kutokana na uwekezaji
-178.31M-28.31%
Pesa kutokana na ufadhili
-27.16M-185.08%
Mabadiliko halisi ya pesa taslimu
334.84M658.87%
Mtiririko huru wa pesa
162.44M123.56%
Kuhusu
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30. Principally a producer of blood plasma–based products, a field in which it is the European leader and third largest worldwide, and other biopharmaceuticals, the company is also in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, in addition to clinical diagnostic technologies. Grifols also provides biological supplies for life-science research, clinical trials and for manufacturing pharmaceutical and diagnostic products. Grifols is focused on four main therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
18 Nov 1940
Wafanyakazi
23,833
Gundua zaidi
Huenda unavutiwa na
Orodha hii imetokana na maudhui uliyotafuta hivi majuzi, hisa unazofuatilia na shughuli zingine. Pata maelezo zaidi

Data na maelezo yote hutolewa “kama yalivyo” kwa madhumuni ya taarifa binafsi tu, wala hayanuii kuwa ushauri wa kifedha na hayana madhumuni ya kufanya biashara au uwekezaji, kodi, kisheria, uhasibu au ushauri mwingine. Google si mshauri wa uwekezaji wala mshauri wa kifedha na haitoi maoni au mapendekezo yanayohusiana na kampuni zozote zilizojumuishwa kwenye orodha hii au hisa zozote zilizotolewa na kampuni hizo. Tafadhali wasiliana na dalali wako au mwakilishi wa kifedha ili uthibitishe bei kabla ya kufanya biashara yoyote. Pata maelezo zaidi
Watu pia hutafuta
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu